Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Stopa

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Heart Journal|January 8, 2024
Leveraging epitranscriptomics for cardiovascular disease theranosticsMiron Sopic, Victoria Stopa, Yvan Devaux
Critical Care (London, England)|February 26, 2026
Blood N1-methyladenosine (m<sup>1</sup>A) RNA modification and outcome after cardiac arrestVictoria Stopa, Miron Sopic, François Bernardin, et al.
Vascular Pharmacology|April 16, 2025
Epitranscriptomics in atherosclerosis: Unraveling RNA modifications, editing and splicing and their implications in vascular diseaseVictoria Stopa, Dimitra Dafou, Korina Karagianni, et al.
Intensive Care Medicine Experimental|September 27, 2024
Multiomic biomarkers after cardiac arrestVictoria Stopa, Gabriele Lileikyte, Anahita Bakochi, et al.
Journal of Molecular and Cellular Cardiology Plus|March 12, 2026
RNA modifications in peripheral blood are associated with acute coronary syndromeMiron Sopic, Victoria Stopa, Jelena Munjas, et al.
British Journal of Pharmacology|June 3, 2024
Circular RNA regulatory role in pathological cardiac remodellingAlessia Bibi, Monika Bartekova, Shrey Gandhi, et al.
Intensive Care Medicine Experimental|January 7, 2026
Direct RNA sequencing identified solute carrier family 2 member 1 to improve neurological outcome prediction after cardiac arrestVictoria Stopa, Miron Sopic, Lu Zhang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Heart Journal|January 8, 2024
Leveraging epitranscriptomics for cardiovascular disease theranosticsMiron Sopic, Victoria Stopa, Yvan Devaux
Critical Care (London, England)|February 26, 2026
Blood N1-methyladenosine (m<sup>1</sup>A) RNA modification and outcome after cardiac arrestVictoria Stopa, Miron Sopic, François Bernardin, et al.
Vascular Pharmacology|April 16, 2025
Epitranscriptomics in atherosclerosis: Unraveling RNA modifications, editing and splicing and their implications in vascular diseaseVictoria Stopa, Dimitra Dafou, Korina Karagianni, et al.
Intensive Care Medicine Experimental|September 27, 2024
Multiomic biomarkers after cardiac arrestVictoria Stopa, Gabriele Lileikyte, Anahita Bakochi, et al.
Journal of Molecular and Cellular Cardiology Plus|March 12, 2026
RNA modifications in peripheral blood are associated with acute coronary syndromeMiron Sopic, Victoria Stopa, Jelena Munjas, et al.
British Journal of Pharmacology|June 3, 2024
Circular RNA regulatory role in pathological cardiac remodellingAlessia Bibi, Monika Bartekova, Shrey Gandhi, et al.
Intensive Care Medicine Experimental|January 7, 2026
Direct RNA sequencing identified solute carrier family 2 member 1 to improve neurological outcome prediction after cardiac arrestVictoria Stopa, Miron Sopic, Lu Zhang, et al.
Pageof 1